Department of Anaesthesiology and Intensive Therapy, Semmelweis University, H-1428 Budapest, Hungary.
Medical Department, EpiConsult Biomedical Consulting and Medical Communication Agency, Dover, DE 19901, USA.
Int J Environ Res Public Health. 2021 May 14;18(10):5223. doi: 10.3390/ijerph18105223.
Proper hemodynamic management is necessary among post-cardiac arrest patients to improve survival. We aimed to investigate the effects of PiCCO™-guided (pulse index contour cardiac output) hemodynamic management on mortality in post-resuscitation therapy. In this longitudinal analysis of 63 comatose patients after successful cardiopulmonary resuscitation cooled to 32-34 °C, 33 patients received PiCCO™, and 30 were not monitored with PiCCO™. Primary and secondary outcomes were 30 day and 1 year mortality. Kaplan-Meier curves and log-rank tests were used to assess differences in mortality among the groups. Interaction effects to disentangle the relationship between patient's condition, PiCCO™ application, and mortality were assessed by means of Chi-square tests and logistic regression models. A 30 day mortality was significantly higher among PiCCO™ patients, while 1 year mortality was marginally higher. More severe patient condition per se was not the cause of higher mortality rate in the PiCCO™ group. Patients in better health conditions (without ST-elevation myocardial infarction, without cardiogenic shock, without intra-aortic balloon pump device, or without stroke in prior history) had worse outcomes with PiCCO™-guided therapy. Catecholamine administration worsened both 30 day and 1 year mortality among all patients. Our analysis showed that there was a complex interaction relationship between PiCCO™-guided therapy, patients' condition, and 30 day mortality for most conditions.
在心脏骤停后患者中进行适当的血流动力学管理对于提高生存率是必要的。我们旨在研究 PiCCO™指导(脉搏指数轮廓心输出量)血流动力学管理对复苏后治疗中死亡率的影响。在这项对 63 例接受心肺复苏后成功复温至 32-34°C 的昏迷患者的纵向分析中,33 例患者接受了 PiCCO™监测,30 例患者未接受 PiCCO™监测。主要和次要结局分别为 30 天和 1 年死亡率。Kaplan-Meier 曲线和对数秩检验用于评估各组死亡率的差异。通过卡方检验和逻辑回归模型评估混杂因素对患者病情、PiCCO™应用和死亡率之间关系的交互作用。PiCCO™患者的 30 天死亡率明显较高,而 1 年死亡率则略高。PiCCO™组更高的死亡率本身并不是患者病情更严重的原因。健康状况更好的患者(没有 ST 段抬高型心肌梗死、没有心源性休克、没有主动脉内球囊泵装置或没有既往卒中史)接受 PiCCO™指导治疗的结局更差。儿茶酚胺的应用使所有患者的 30 天和 1 年死亡率都恶化。我们的分析表明,在大多数情况下,PiCCO™指导治疗、患者病情和 30 天死亡率之间存在复杂的相互作用关系。